Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

Stanley Schwartz1, Benjamin A Kohl21Department of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 2Department of Anesthesiology and Critical Care, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USAAbstract: The rates...

Full description

Bibliographic Details
Main Author: Schwartz S
Format: Article
Language:English
Published: Dove Medical Press 2010-07-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
Type 2 Diabetes
diabetes treatment
incretin-based therapies
glucose control
GLP-1
Cardiovascular disease
Online Access:https://www.dovepress.com/type-2-diabetes-mellitus-and-the-cardiometabolic-syndrome-impact-of-in-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/type-2-diabetes-mellitus-and-the-cardiometabolic-syndrome-impact-of-in-peer-reviewed-article-DMSO

Similar Items